UNLABELLED: Coinfection with hepatitis C virus (HCV) is present in one-third of all human immunodeficiency virus (HIV)-infected individuals in the United States and is associated with rapid progression of liver fibrosis and poor response to pegylated interferon (IFN) and ribavirin. In this study we examined gene expression profiles in peripheral blood mononuclear cells (PBMCs) from different groups of individuals who are monoinfected or coinfected with HIV and HCV. Data showed that HIV and HCV viremia up-regulate genes associated with immune activation and immunoregulatory pathways. HCV viremia is also associated with abnormalities in all peripheral immune cells, suggesting a global effect of HCV on the immune system. Interferon-alpha-induced genes were expressed at a higher level in PBMCs from HIV-infected individuals. HCV and HIV infections leave distinct profiles or gene expression of immune activation in PBMCs. HIV viremia induces an immune activated state; by comparison, HCV infection induces immunoregulatory and proinflammatory pathways that may contribute to progression of liver fibrosis. CONCLUSION: An aberrant type-I IFN response seen exclusively in HIV-infected individuals could be responsible for the poor therapeutic response experienced by HIV/HCV coinfected individuals receiving interferon-alpha-based current standard of care.
UNLABELLED: Coinfection with hepatitis C virus (HCV) is present in one-third of all humanimmunodeficiency virus (HIV)-infected individuals in the United States and is associated with rapid progression of liver fibrosis and poor response to pegylated interferon (IFN) and ribavirin. In this study we examined gene expression profiles in peripheral blood mononuclear cells (PBMCs) from different groups of individuals who are monoinfected or coinfected with HIV and HCV. Data showed that HIV and HCV viremia up-regulate genes associated with immune activation and immunoregulatory pathways. HCV viremia is also associated with abnormalities in all peripheral immune cells, suggesting a global effect of HCV on the immune system. Interferon-alpha-induced genes were expressed at a higher level in PBMCs from HIV-infected individuals. HCV and HIV infections leave distinct profiles or gene expression of immune activation in PBMCs. HIV viremia induces an immune activated state; by comparison, HCV infection induces immunoregulatory and proinflammatory pathways that may contribute to progression of liver fibrosis. CONCLUSION: An aberrant type-I IFN response seen exclusively in HIV-infected individuals could be responsible for the poor therapeutic response experienced by HIV/HCV coinfected individuals receiving interferon-alpha-based current standard of care.
Authors: Mamta K Jain; Daniel J Skiest; Jeff W Cloud; Charu L Jain; Dennis Burns; Ruth E Berggren Journal: Clin Infect Dis Date: 2003-04-02 Impact factor: 9.079
Authors: Nikolaos V Sipsas; Petros P Sfikakis; Giota Touloumi; Nikos Pantazis; Helen Choremi; Theodore Kordossis Journal: AIDS Patient Care STDS Date: 2003-04 Impact factor: 5.078
Authors: Hermann E Wasmuth; Mirko Moreno Zaldivar; Marie-Luise Berres; Alexa Werth; David Scholten; Sonja Hillebrandt; Frank Tacke; Petra Schmitz; Edgar Dahl; Tonio Wiederholt; Claus Hellerbrand; Thomas Berg; Ralf Weiskirchen; Christian Trautwein; Frank Lammert Journal: J Hepatol Date: 2007-11-20 Impact factor: 25.083
Authors: Tae-Wook Chun; J Shawn Justement; Richard A Lempicki; Jun Yang; Glynn Dennis; Claire W Hallahan; Christina Sanford; Punita Pandya; Shuying Liu; Mary McLaughlin; Linda A Ehler; Susan Moir; Anthony S Fauci Journal: Proc Natl Acad Sci U S A Date: 2003-01-27 Impact factor: 11.205
Authors: Francesca J Torriani; Ruy M Ribeiro; Tari L Gilbert; Uschi M Schrenk; Marietta Clauson; DeeDee M Pacheco; Alan S Perelson Journal: J Infect Dis Date: 2003-11-13 Impact factor: 5.226
Authors: Madeline Odigie; Anu Osinusi; Lisa Barrett; Kerry Townsend; Honghui Wang; Anthony F Suffredini; Henry Masur; Michael A Polis; Shyam Kottilil Journal: AIDS Res Hum Retroviruses Date: 2014-06-30 Impact factor: 2.205
Authors: Rafael Fernandez-Botran; Swati Joshi-Barve; Smita Ghare; Shirish Barve; Mary Young; Michael Plankey; Jose Bordon Journal: J Interferon Cytokine Res Date: 2014-06-23 Impact factor: 2.607
Authors: Nirzari Parikh; Michael R Nonnemacher; Vanessa Pirrone; Timothy Block; Anand Mehta; Brian Wigdahl Journal: Curr HIV Res Date: 2012-10 Impact factor: 1.581
Authors: Antonios Katsounas; Joseph J Rasimas; Joerg F Schlaak; Richard A Lempicki; Donald L Rosenstein; Shyam Kottilil Journal: J Med Virol Date: 2014-04-30 Impact factor: 2.327
Authors: Angela L Rasmussen; I-Ming Wang; Margaret C Shuhart; Sean C Proll; Yudong He; Razvan Cristescu; Chris Roberts; Victoria S Carter; Christopher M Williams; Deborah L Diamond; Janine T Bryan; Roger Ulrich; Marcus J Korth; Lisa V Thomassen; Michael G Katze Journal: Virology Date: 2012-05-16 Impact factor: 3.616
Authors: Astrid C Frank; Xiaozhen Zhang; Antonios Katsounas; Jennifer P Bharucha; Shyamasundaran Kottilil; Tomozumi Imamichi Journal: J Interferon Cytokine Res Date: 2010-06 Impact factor: 2.607